Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ADVANCED MEDICAL SOLUTIONS GROUP PLC

(AMS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 587636523687--
Entreprise Value (EV)1 511571481622607592
P/E ratio 26,2x33,9x61,7x40,6x34,8x31,2x
Yield 0,48%0,52%0,70%0,60%0,67%0,74%
Capitalization / Revenue 5,72x6,21x6,03x6,24x5,86x5,41x
EV / Revenue 4,98x5,58x5,54x5,65x5,18x4,67x
EV / EBITDA 16,5x18,7x26,8x20,6x18,1x15,6x
Price to Book 3,39x3,32x2,62x3,56x3,43x3,26x
Nbr of stocks (in thousands) 213 479214 891215 384215 998--
Reference price (GBP) 2,752,962,433,183,183,18
Announcement Date 03/13/201903/11/202003/17/2021---
1 GBP in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 10310286,8110117127
EBITDA1 30,930,617,930,133,538,0
Operating profit (EBIT)1 28,727,514,525,628,232,1
Operating Margin 28,0%26,8%16,6%23,2%24,1%25,3%
Pre-Tax Profit (EBT)1 28,424,310,121,725,429,6
Net income1 22,718,98,5817,019,822,2
Net margin 22,1%18,5%9,89%15,4%16,9%17,5%
EPS2 0,100,090,040,080,090,10
Dividend per Share2 0,010,020,020,020,020,02
Announcement Date 03/13/201903/11/202003/17/2021---
1 GBP in Million
2 GBP
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2017 S2 2018 S1 2018 S2 2019 S1 2020 S1 2021 S2
Net sales1 51,047,655,048,739,359,0
EBITDA1 16,0-16,213,7-16,3
Operating profit (EBIT)1 13,9-15,1-5,5013,8
Operating Margin 27,2%-27,5%-14,0%23,4%
Pre-Tax Profit (EBT)1 13,9----12,1
Net income1 11,0----9,70
Net margin 21,6%----16,4%
EPS2 0,05----0,04
Dividend per Share ------
Announcement Date 03/14/201809/12/201803/13/201909/11/201909/16/2020-
1 GBP in Million
2 GBP
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 76,464,842,765,179,794,5
Leverage (Debt / EBITDA) -2,48x-2,12x-2,38x-2,16x-2,38x-2,49x
Free Cash Flow1 17,319,019,218,820,523,4
ROE (Net Profit / Equities) 13,9%10,4%4,36%11,0%10,4%10,8%
Shareholders' equity1 163182197155191206
ROA (Net Profit / Asset) 12,4%8,75%3,69%5,60%7,50%8,40%
Assets1 182216233304264264
Book Value Per Share2 0,810,890,930,890,930,98
Cash Flow per Share2 0,090,100,100,050,100,12
Capex1 3,062,672,354,555,413,83
Capex / Sales 2,98%2,61%2,70%4,13%4,62%3,02%
Announcement Date 03/13/201903/11/202003/17/2021---
1 GBP in Million
2 GBP
Key data
Capitalization (GBP) 686 874 603
Capitalization (USD) 908 203 891
Net sales (GBP) 86 796 000
Net sales (USD) 114 839 788
Number of employees 700
Sales / Employee (GBP) 123 994
Sales / Employee (USD) 164 057
Free-Float 92,8%
Free-Float capitalization (GBP) 637 409 105
Free-Float capitalization (USD) 842 799 293
Avg. Exchange 20 sessions (GBP) 93 772 234
Avg. Exchange 20 sessions (USD) 124 070 042
Average Daily Capital Traded 13,7%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA